Ameera Shah said the professional journey for women still involves dealing with visible and predictable blocks of time away from work, which organisations seldom plan for
The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes
Novo Nordisk has launched Ozempic, its once-weekly semaglutide injection for adults with type 2 diabetes, in the Indian market. The GLP-1 therapy, already widely used globally, offers blood-sugar con...
Servier India has received approval for Vorasidenib (Voranigo), adding a second rare-cancer treatment to its portfolio in the country. The targeted IDH inhibitor offers an option for patients with Gra...
Servier India to launch Vorasidenib (Voranigo), a targeted therapy for patients with Grade 2 IDH-mutant glioma
Days before Ozempic’s India debut, Centre cautions that GLP-1 drugs carry unknown long-term risks and are being adopted faster than scientific evidence can support
The company is evaluating obesity pipeline but ruled out ‘me-too’ GLP-1 or GIP drugs.
IQVIA and AWS said the collaboration reflects the growing need for cloud-based tools that can support large-scale trial operations and analytical workloads.
AWS is entering a phase where companies will move beyond copilots and assistants to AI agents capable of completing full tasks across IT, operations, security, customer workflows and data-heavy enviro...
AWS also introduced the Trainium 3 chip and new AI-optimised servers designed to handle resource-intensive healthcare workloads such as genomics pipelines, biomarker discovery, molecular-simulation ta...
India Today@50 | India Today Group Leadership Rings NSE Ceremonial Bell
Brahmani Nara Discusses Purpose, Impact And Why Politics Isn’t On Her Horizon | #BTMPW2025
Brahmani Nara On Carving Her Own Path, Steering Heritage Foods Toward Value-Added Growth | #BTMPW2025
The Big Consumer Evolution | Anupriya Acharya On Brands, Data & New India | #BTMPW2025
#BTMPW2025 | India’s Next-Gen Women Leaders Share Powerful Leadership Insights
